Data di pubblicazione	Titolo	Autore(i)	Tipo	File
1	gen-2013	When phylogenetic analysis complements the epidemiological investigation: a case of HIV-2 infection, Italy	Ciccozzi, M; Callegaro, A; Lo Presti, A; Cella, E; Giovanetti, M; Salpini, R; Babakir-Mina, M; Farina, C; Maggiolo, F; Perno, C; Ciotti, M	Articolo su rivista	-
2	27-nov-2009	When and how to use maraviroc in HIV-infected patients	Soriano, V; Perno, C; Kaiser, R; Calvez, V; Gatell, J; di Perri, G; Pillay, D; Rockstroh, J; Geretti, A	Articolo su rivista	-
3	2007	Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation	Antinori, A; Trotta, M; Lorenzini, P; Torti, C; Gianotti, N; Maggiolo, F; Ceccherini-Silberstein, F; Nasto, P; Castagna, A; De Luca, A; Mussini, C; Andreoni, M; Perno, C	Articolo su rivista	-
4	gen-2017	Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens	Armenia, D; Di Carlo, D; Maffongelli, G; Borghi, V; Alteri, C; Forbici, F; Bertoli, A; Gori, C; Giuliani, M; Nicastri, E; Zaccarelli, M; Pinnetti, C; Cicalini, S; D'Offizi, G; Ceccherini-Silberstein, F; Mussini, C; Antinori, A; Andreoni, M; Perno, C; Santoro, M	Articolo su rivista	riservati
5	15-dic-2002	Virologic correlates of adherence to antiretroviral medications and therapeutic failure	Perno, C; Ceccherini-Silberstein, F; De Luca, A; Cozzi-Lepri, A; Gori, C; Cingolani, A; Bellocchi, M; Trotta, M; Piano, P; Forbici, F; Scasso, A; Vullo, V; d'Arminio Monforte, A; Antinori, A	Articolo su rivista	-
6	22-set-2017	Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice	Santoro, M; Di Carlo, D; Armenia, D; Zaccarelli, M; Pinnetti, C; Colafigli, M; Prati, F; Boschi, A; Antoni, A; Lagi, F; Sighinolfi, L; Gervasoni, C; Andreoni, M; Antinori, A; Mussini, C; Perno, C; Borghi, V; Sterrantino, G	Articolo su rivista	-
7	gen-2008	Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study	Santoro, M; Bertoli, A; Lorenzini, P; Lazzarin, A; Esposito, R; Carosi, G; Di Perri, G; Filice, G; Moroni, M; Rizzardini, G; Caramello, P; Maserati, R; Narciso, P; Cargnel, A; Antinori, A; Perno, C	Articolo su rivista	-
8	dic-2009	Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007	Puzelli, S; Valdarchi, C; Ciotti, M; Dorrucci, M; Farchi, F; Babakir-Mina, M; Perno, CF; Donatelli, I; Rezza, G	Articolo su rivista	-
9	ago-2014	A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.	Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, AG; Calvez, V; Antinori A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM	Articolo su rivista	Open Access
10	2004	Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems	De Luca, A; Cozzi-Lepri, A; Perno, CF; Balotta, C; Di Giambenedetto, S; Poggio, A; Pagano, G; Tositti, G; Piscopo, R; Del Forno, A; Chiodo, F; Magnani, G; D'Arminio Monforte, A	Articolo su rivista	-
11	mar-2010	Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir	Tommasi, C; Ceccherini-Silberstein, F; D'Arrigo, R; Bellagamba, R; Tempestilli, M; Dessì, C; Santoro, MM; Forbici, F; Nicastri, E; Pucillo, LP; Perno, CF; Narciso, P	Articolo su rivista	-
12	dic-2004	Updated European recommendations for the clinical use of HIV drug resistance testing	Vandamme, A; Sönnerborg, A; Ait-Khaled, M; Albert, J; Asjo, B; Bacheler, L; Banhegyi, D; Boucher, C; Brun-Vézinet, F; Camacho, R; Clevenbergh, P; Clumeck, N; Dedes, N; De Luca, A; Doerr, H; Faudon, J; Gatti, G; Gerstoft, J; Hall, W; Hatzakis, A; Hellmann, N; Horban, A; Lundgren, J; Kempf, D; Miller, M; Miller, V; Myers, T; Nielsen, C; Opravil, M; Palmisano, L; Perno, C; Phillips, A; Pillay, D; Pumarola, T; Ruiz, L; Salminen, M; Schapiro, J; Schmidt, B; Schmit, J; Schuurman, R; Shulse, E; Soriano, V; Staszewski, S; Vella, S; Youle, M; Ziermann, R; Perrin, L	Articolo su rivista	-
13	nov-2015	An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project	Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, Mm; Clementi, M; Perno, Cf; d'Arminio Monforte, A; Maggiolo, F; Castagna, A; De Luca, A; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A	Articolo su rivista	Open Access
14	giu-2014	Understanding HIV compartments and reservoirs	Svicher, V; Ceccherini-Silberstein, F; Antinori, A; Aquaro, S; Perno, C	Articolo su rivista	Solo autorizzati
15	14-gen-2017	Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation	Jaffré, J; Armenia, D; Bellocchi, Mc; Wirden, M; Carioti, L; Lambert, S; Valantin, M; Nguyen, T; Simon, A; Katlama, C; Andreoni, M; Perno, Cf; Calvez, V; Ceccherini-Silberstein, F; Marcelin, A; Todesco, E	Articolo su rivista	riservati
16	giu-2009	Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients	Santoro, M; Bertoli, A; Lorenzini, P; Ceccherini-Silberstein, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, C	Articolo su rivista	-
17	set-2016	Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART	Squillace, N; Lorenzini, P; Lapadula, G; Bandera, A; Cozzi-Lepri, A; Rusconi, S; Puoti, M; Castagna, A; Antinori, A; Gori, A; d'Arminio Monforte, A; Perno, CF	Articolo su rivista	riservati
18	lug-2009	Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev	Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, C; Ceccherini-Silberstein, F	Articolo su rivista	-
19	2017	Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel	Vigano, M; Perno, Cf; Craxi, A	Articolo su rivista	Solo autorizzati
20	28-nov-2017	Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy	Brancaccio, G; Sorbo, Mc; Frigeri, F; Rizzo, V; Cantone, M; Genderini, F; Fabeni, L; Pinto, A; Perno, Cf; Ceccherini-Silberstein, F; Gaeta, Gb	Articolo su rivista	-